Sixty-four patients with recurrent or metastatic colorectal cancer underwent radioimmunoguided surgery (RIGS). Thirty patients (Group A) were preoperatively injected with radiolabeled monoclonal antibody (MAb) B72.3, a whole IgG1 that reacts with tumor-associated glycoprotein (TAG-72) antigen. Thirt
In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer
β Scribed by Ralph J. Doerr; Lemuel Herrera; Hani Abdel-Nabi
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 719 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The monoclonal antibody (MAb) 791T/36 which has previously been shown to localise in colorectal cancer has been conjugated to methotrexate (MTX) for potential use as a chemotherapeutic agent in malignant disease. To examine its biodistribution and tumour localisation, 16 patients with primary colore
We have developed a sensitive ELISA using MAb 4D3 for the detection of a novel epitope on Small Intestinal Mucin Antigen (SIMA) and report here that SlMA is present in the serum of patients with colorectal cancer. SlMA has been shown to occur in tissue from a high proportion of patients with colorec